Batterham M, Garsia R & Greenop P (2000) Dietary intake, serum lipids, insulin resistance and body composition in the era of HAART 'Diet FRS Study'. AIDS 14, 1839–1843.
Bell SJ, Chavali S, Bistrian B, Connolly CA, Utsonomiya T & Forse RA (1996) Dietary fish oil and cytokine production during HIV infection. Journal of Parenteral and Enteral Nutrition 20, 43–49.
Brinkman K, Hofstede H, Burger D, Smeitinik J & Koopmans P (1998) Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12, 1735–1744.
Brinkman K, Smeitinik J, Romjin J & Reiss P (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354, 1112–1115.
Calder PC (1996) Effects of fatty acids and dietary lipids on cells of the immune system. Proceedings of the Nutrition Society 55, 127–150.
Carr A & Cooper D (2000) Adverse effects of antiretroviral therapy. Lancet 356, 1423–1430.
Carr A, Samaras K, Chisholm D & Cooper D (1998) Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 352, 1881–1883.
Carr A, Samaras K, Thorisdottir A, Kauffman G, Chisholm D & Cooper D (1999) Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353, 2093–2099.
Christeff N, Lortholary O, Casassus P, Thobie N, Dalle M, Veyssier P, Guillevin L & Nunez E (1995) Serum lipid concentration with reference to the clinical and immunological status of HIV infected men. Annales de Médecine Interne 146, 490–495.
Cloyd MW (1991) Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology 181, 500–511.
Constans J, Pellegrin J & Peuchant E (1994) Plasma lipids in HIV-infected patients: a prospective study in 95 patients. European Journal of Clinical Investigation 24, 416–420.
Constans J, Peuchant E & Pellegrin J (1995) Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunological status. Clinical Biochemistry 28, 421–426.
Endres S (1993) Messengers and mediators: interactions among lipids, eicosanoids and cytokines. American Journal of Clinical Nutrition 57, 7895–8005.
Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JMW, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaeffer EJ, Wolff SM & Dinarello CA (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. New England Journal of Medicine 320, 265–271.
Feingold K, Adi S, Staprins I, Moser A, Neese R, Verdier JA, Doerrler W & Grunfeld C (1990) Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. American Journal of Physiology 259, E177–E184.
Fernandez-Miranda C, Pulido F & Carrillo JL (1998) Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers. Clinica Chimica Acta 274, 63–70.
Frayn K, Shadid S, Hamlani R, Humphreys S, Clark ML, Fielding BA, Boland O & Coppack SW (1994) Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. American Journal of Physiology 266, E308–E317.
Gazzard B (editor) (1999) Weight loss and diarrhoea. In Chelsea and Westminster Hospital AIDS Care Handbook, pp. 201–214. London: Mediscript Ltd.
Gomez-Sirvent JL, Alonso-Socas MM, Santolaria-Fernandez FJ, Gonzalez-Reimers CE, Rodriguez-Moreno F & Essardas-Daryanani H (1994) Prognostic value of triglyceride levels in early HIV infection. AIDS 8, 1740–1741.
Grunfeld C & Feingold K (1991) The metabolic effects of tumour necrosis factor and other cytokines. Biotherapy 3, 143–158.
Grunfeld C & Feingold K (1992) Metabolic disturbances and wasting in AIDS. New England Journal of Medicine 327, 329–335.
Grunfeld C, Kotler D & Shigenaga (1991) Circulating IFN-alpha and hypertriglyceridaemia in AIDS. American Journal of Medicine 90, 154–162.
Grunfeld C, Pang M, Doerrler W, Shigenaga J, Jensen P & Feingold K (1992) Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Journal of Clinical Endocrinology and Metabolism 74, 1045–1052.
Hellerstein M, Grunfield C, Wu K, Christiansen M, Kaempfer S, Kletke C & Shackleton C (1993) Increased de novo hepatic lipogenesis in HIV infection. Journal of Clinical Endocrinology and Metabolism 76, 559–565.
Hommes M, Romjin J, Endert E & Sauerwein H (1991) Resting energy expenditure and substrate oxidation in HIV-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. American Journal of Clinical Nutrition 54, 311–315.
Jahoor F, Jackson AA, Gazzard B, Phillips G, Sharpstone D, Frazer M & Heird W (1999) Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. American Journal of Physiology 276, E205–E211.
Klein A, Bruser B, Bast M & Rachlis A (1992) Progress of HIV infection and changes in the lipid membrane structure of CD4+ cells. AIDS 6, 332–333.
Koppel K (2000) Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection. International Journal of STD and AIDS 11, 451–455.
Kotler D & Heymsfield S (1998) HIV Infection: a model chronic illness for studying wasting diseases. American Journal of Clinical Nutrition 68, 519–520.
Mallal S, John M, Moore C, James I & McKinnon E (2000) Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14, 1309–1316.
Mercie P (2000) Atherogen lipid profile in HIV-1 infected patients with lipodystrophy syndrome. European Journal of Internal Medicine 11, 257–263.
Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello C & Gorbach SL (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. Journal of Nutrition 121, 547–555.
Meyer L, Rabaud C, Ziegler O, May T & Drouin P (1998) Protease inhibitors, diabetes mellitus and blood lipids. Diabetes Metabolism 24, 547–549.
Mulligan K, Grunfeld C, Hellerstein M, Neese R & Schambelan M (1993) Anabolic effects of recombinant human growth hormone in patients with wasting associated with HIV infection. Journal of Clinical Endocrinology and Metabolism 77, 956–962.
Noor MA, Lo JC, Mulligan K, Shwarz JM, Halvorsen RA, Schambelan M & Grunfeld C (2001) Absent HIV infection, Indinavir causes insulin resistance. AIDS 15, 11–18.
Nunez E & Christeff N (1994) Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infection. Baillieres Clinical Endocrinology and Metabolism 8, 803–824.
Pacht ER, Diaz P, Clanton T, Hart J & Gaadek JE (1997) Serum vitamin E decreases in HIV-seropositive subjects over time. Journal of Laboratory and Clinical Medicine 130, 293–296.
Purnell J, Zambon A, Knopp R et al. (1999) Effect of Ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 14, 51–57.
Roubenouff R, Weiss L, McDermott A, Heflin T, Cloutier G, Wood M & Gorbach S (1999) A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 13, 1373–1375.
Sappey C, Leclercq P, Coudray C, Faure P, Micoud M & Favier A (1994) Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clinica Chimica Acta 230, 35–42.
Silva M, Skolnik PR, Gorbach SL, Spiegelman D, Wilson IB, Fernandez-Di Franco MG & Knox TA (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12, 1645–1651.
Sullivan AK, Feher MD, Nelson MR & Gazzard BG (1998) Marked hypertriglyceridaemia associated with ritonavir therapy. AIDS 12, 1393–1395.
Taskinen MR (1995) Insulin resistance and lipoprotein metabolism. Current Opinion in Lipidology 6, 153–160.
Tikkanen MJ, Ojala J & Helve E (1992) Long term use of Lovastatin in different types of hyperlipidaemia. Atherosclerosis 97, S27–S32.
Turcotte L, Srivastava A & Chiasson J (1997) Fasting increases plasma membrane fatty acid-binding protein in red skeletal muscle. Molecular and Cellular Biochemistry 166, 153–158.
Ware LJ, Morlese J, Burdge G, Jackson AA, Gazzard B & Wooton SA (2000) Differences in postprandial lipid metabolism in patients with PI-associated and NRTI-associated lipodystrophy. Antiviral Therapy 5, Suppl. 5, 13.
Ware LJ, Morlese J, Gazzard B, Burdge GC, Jackson AA & Wooton SA (2001) Highly active anti-retroviral therapy (HAART) in HIV-1 positive men increases the retention time of dietary lipid within the circulation. Proceedings of the Nutrition Society 60, 31A.
Xiang S, Cianflone K, Kalant D & Sniderman A (1999) Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. Journal of Lipid Research 40, 1655–1662.
Yarasheski K, Tebas P & Stanerson B (2001) Resistance exercise training reduces hypertriglyceridaemia in HIV-infected men treated with antiviral therapy. Journal of Applied Physiology 90, 133–138.